vs
Esperion Therapeutics, Inc.（ESPR）与CarParts.com, Inc.（PRTS）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是CarParts.com, Inc.的1.4倍（$168.4M vs $120.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -9.8%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -8.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
GPC是一家总部位于美国佐治亚州亚特兰大的汽车与工业零部件分销商，1928年由弗雷泽兄弟创立，目前拥有约六万名员工。除美国本土市场外，公司业务还覆盖澳大拉西亚、比利时、加拿大、法国、德国、墨西哥、荷兰、波兰及英国，旗下拥有知名汽车零部件零售商NAPA Auto Parts和工业零部件分销商Motion。
ESPR vs PRTS — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$120.4M
营收增速更快
ESPR
高出153.5%
-9.8%
两年增速更快
ESPR
近两年复合增速
-8.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $120.4M |
| 净利润 | — | $-11.6M |
| 毛利率 | — | 33.2% |
| 营业利润率 | 50.6% | — |
| 净利率 | — | -9.6% |
| 营收同比 | 143.7% | -9.8% |
| 净利润同比 | — | 25.0% |
| 每股收益（稀释后） | $0.32 | $-0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPRTS
| Q4 25 | $168.4M | $120.4M | ||
| Q3 25 | $87.3M | $127.8M | ||
| Q2 25 | $82.4M | $151.9M | ||
| Q1 25 | $65.0M | $147.4M | ||
| Q4 24 | $69.1M | $133.5M | ||
| Q3 24 | $51.6M | $144.8M | ||
| Q2 24 | $73.8M | $144.3M | ||
| Q1 24 | $137.7M | — |
净利润ESPRPRTS
| Q4 25 | — | $-11.6M | ||
| Q3 25 | $-31.3M | $-10.9M | ||
| Q2 25 | $-12.7M | $-12.7M | ||
| Q1 25 | $-40.5M | $-15.3M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | $-29.5M | $-10.0M | ||
| Q2 24 | $-61.9M | $-8.7M | ||
| Q1 24 | $61.0M | — |
毛利率ESPRPRTS
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 33.1% | ||
| Q2 25 | — | 32.8% | ||
| Q1 25 | — | 32.1% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 33.5% | ||
| Q1 24 | — | — |
营业利润率ESPRPRTS
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | -7.9% | ||
| Q2 25 | 8.6% | -8.2% | ||
| Q1 25 | -34.0% | -10.3% | ||
| Q4 24 | -6.4% | -11.6% | ||
| Q3 24 | -31.0% | -6.9% | ||
| Q2 24 | 3.5% | -6.0% | ||
| Q1 24 | 52.5% | — |
净利率ESPRPRTS
| Q4 25 | — | -9.6% | ||
| Q3 25 | -35.9% | -8.5% | ||
| Q2 25 | -15.4% | -8.4% | ||
| Q1 25 | -62.2% | -10.4% | ||
| Q4 24 | — | -11.5% | ||
| Q3 24 | -57.2% | -6.9% | ||
| Q2 24 | -83.9% | -6.0% | ||
| Q1 24 | 44.3% | — |
每股收益（稀释后）ESPRPRTS
| Q4 25 | $0.32 | $-0.82 | ||
| Q3 25 | $-0.16 | $-0.19 | ||
| Q2 25 | $-0.06 | $-0.23 | ||
| Q1 25 | $-0.21 | $-0.27 | ||
| Q4 24 | $-0.14 | $-0.28 | ||
| Q3 24 | $-0.15 | $-0.17 | ||
| Q2 24 | $-0.33 | $-0.15 | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $25.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $53.5M |
| 总资产 | $465.9M | $184.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRPRTS
| Q4 25 | $167.9M | $25.8M | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — | ||
| Q1 24 | $226.6M | — |
股东权益ESPRPRTS
| Q4 25 | $-302.0M | $53.5M | ||
| Q3 25 | $-451.4M | $64.2M | ||
| Q2 25 | $-433.5M | $62.4M | ||
| Q1 25 | $-426.2M | $72.8M | ||
| Q4 24 | $-388.7M | $85.2M | ||
| Q3 24 | $-370.2M | $97.2M | ||
| Q2 24 | $-344.2M | $103.9M | ||
| Q1 24 | $-294.3M | — |
总资产ESPRPRTS
| Q4 25 | $465.9M | $184.9M | ||
| Q3 25 | $364.0M | $200.3M | ||
| Q2 25 | $347.1M | $189.6M | ||
| Q1 25 | $324.0M | $216.5M | ||
| Q4 24 | $343.8M | $210.6M | ||
| Q3 24 | $314.1M | $227.6M | ||
| Q2 24 | $352.3M | $238.0M | ||
| Q1 24 | $373.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRPRTS
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $-6.4M | ||
| Q2 25 | $-31.4M | $-25.6M | ||
| Q1 25 | $-22.6M | $5.5M | ||
| Q4 24 | $-35.0M | $1.8M | ||
| Q3 24 | $-35.3M | $8.5M | ||
| Q2 24 | $-7.2M | $-3.6M | ||
| Q1 24 | $53.8M | — |
自由现金流ESPRPRTS
| Q4 25 | — | — | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | — | $-27.9M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | — | $-631.0K | ||
| Q3 24 | $-35.5M | $4.9M | ||
| Q2 24 | $-7.3M | $-10.8M | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRPRTS
| Q4 25 | — | — | ||
| Q3 25 | — | -6.5% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | -68.7% | 3.4% | ||
| Q2 24 | -9.9% | -7.5% | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRPRTS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 1.4% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.3% | 2.5% | ||
| Q2 24 | 0.1% | 4.9% | ||
| Q1 24 | 0.1% | — |
现金转化率ESPRPRTS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PRTS
暂无分部数据
